Dual targeting of retinoid X receptor and histone deacetylase with DW22 as a novel antitumor approach

Retinoid X receptor (RXR) and Histone deacetylase (HDAC) are considered important targets for cancer therapy due to their crucial roles in genetic or epigenetic regulations of cancer development and progression. Here, we evaluated the potential of dual targeting of RXR and HDAC using DW22 as a novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lihui, Chen, Guoliang, Chen, Kang, Ren, Yong, Li, Huahuan, Jiang, Xiaorui, Jia, Lina, Fu, Shiyuan, Li, Yi, Liu, Xinwei, Wang, Shuang, Yang, Jingyu, Wu, Chunfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496394/
https://www.ncbi.nlm.nih.gov/pubmed/25762635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496394/
https://www.ncbi.nlm.nih.gov/pubmed/25762635

Ejemplares similares